Concepedia
Statistics
Publications
14
Citations
2.5K
H-Index
13
Active since
2000
Affiliations
Amgen (United States)(Current)
Pfizer (United States)
AbbVie (United States)
AstraZeneca (United Kingdom)
Christopher J. Borths is an author at Amgen (United States) specializing in pharmacy, chemistry, and catalysis.
Publications per year
2000–2022
New Strategies for Organic Catalysis: The First Highly Enantioselective Organocatalytic Diels−Alder Reaction
Kateri A. Ahrendt, Christopher J. Borths, David W. C. MacMillan · Journal of the American Chemical Society · 2000 · 1.7K citations
Natural Sciences, Chemistry, Biocatalysis +9
A Highly Efficient Palladium/Copper Cocatalytic System for Direct Arylation of Heteroarenes: An Unexpected Effect of Cu(Xantphos)I
Jinkun Huang, Johann Chan, Ying Chen et al. · Journal of the American Chemical Society · 2010 · 323 citations
Natural Sciences, Chemical Engineering, Chemistry +17
SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm
Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel et al. · Cancer Research · 2015 · 135 citations
Life Sciences, Molecular Biology, Oncology +17
Structural Characterization of a Monoclonal Antibody–Maytansinoid Immunoconjugate
Quanzhou Luo, Hyo Helen Chung, Christopher J. Borths et al. · Analytical Chemistry · 2015 · 59 citations
Pharmacy, Medicinal Chemistry, Molecular Biology +17
Highly Selective Rhodium-Catalyzed Conjugate Addition Reactions of 4-Oxobutenamides
Jamie L. Zigterman, Jacqueline C. S. Woo, Shawn D. Walker et al. · The Journal of Organic Chemistry · 2007 · 54 citations
Natural Sciences, Chemistry, Catalysis +15
1–5 of 14